Leonid Kirnarsky

Title: Leonid Kirnarsky: Innovator in C5a Anaphylatoxin Research

Introduction

Leonid Kirnarsky is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of biochemistry, particularly in the development of high-affinity response-selective C-terminal analogs of C5a anaphylatoxin. With a total of 3 patents, his work has implications for understanding and manipulating biological responses.

Latest Patents

Kirnarsky's latest patents focus on high-affinity response-selective C-terminal analogs of C5a anaphylatoxin. These analogs possess a constrained backbone conformation at the C-terminus, which enhances their potency. The stabilized β-turn motif allows these compounds to selectively elicit specific biological responses associated with C5a. Exemplary compounds include decapeptide analogs of the formula: A1-Ser-Phe-Lys-A2-A3-A4-A5-A6-A7, with the constrained β-turn localized in the region of A4-A7.

Career Highlights

Throughout his career, Kirnarsky has worked with prestigious institutions such as the University of Nebraska and The University of Queensland. His research has contributed to advancements in the understanding of anaphylatoxins and their biological roles.

Collaborations

Some of his notable coworkers include Sam D Sanderson and Simon A Sherman. Their collaborative efforts have furthered the research in the field of anaphylatoxins.

Conclusion

Leonid Kirnarsky's innovative work in the development of C5a anaphylatoxin analogs showcases his significant contributions to biochemistry. His patents reflect a commitment to advancing scientific knowledge and potential therapeutic applications.